Exercise intolerance in cancer and the role of exercise therapy to reverse dysfunction
- 1 June 2009
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 10 (6) , 598-605
- https://doi.org/10.1016/s1470-2045(09)70031-2
Abstract
No abstract availableKeywords
This publication has 67 references indexed in Scilit:
- Early drug development of inhibitors of the insulin-like growth factor-I receptor pathway: Lessons from the first clinical trialsMolecular Cancer Therapeutics, 2008
- AMPK and PPARδ Agonists Are Exercise MimeticsCell, 2008
- Cancer Survivors’ Adherence to Lifestyle Behavior Recommendations and Associations With Health-Related Quality of Life: Results From the American Cancer Society's SCS-IIJournal of Clinical Oncology, 2008
- Mechanisms of exertional dyspnea in patients with cancerJournal of Applied Physiology, 2008
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibPublished by Elsevier ,2007
- Where is VEGF in the body? A meta-analysis of VEGF distribution in cancerBritish Journal of Cancer, 2007
- A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients: The Benefit Depends on the Type of Training PerformedPublished by Elsevier ,2007
- Physical Activity and Survival After Breast Cancer DiagnosisJAMA, 2005
- Diffusive resistance to O2 transport in muscleActa Physiologica Scandinavica, 2000
- Hemodynamic adaptations to exerciseThe American Journal of Cardiology, 1985